DYN
Dyne Therapeutics, Inc. · Healthcare
Atlas Venture Opportunity Fund Ii, L.P. bought $10.0M of Dyne Therapeutics, Inc.
10% owner
Bought$10,000,017
$10.70Price
934,581Shares
+10%Stake
What DYN did for a copier
- $1,000 copied at Thu, Dec 15 open, $14.08
- $1,037
- S&P 500, same days
- +3.6%
Measured over 30 trading days, to the Jan 31 close.
Atlas Venture Opportunity Fund Ii, L.P.'s record
1 other buy on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Dec 12. Filed Wed, Dec 14, 4:55 PM ET, after the close. Returns use the Dec 15 open and the Jan 31 close. Not investment advice.